Portfolio (Quarterly)
Guide ↗
BRAIDWELL LP
· CIK 0001920938| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | DYN | DYNE THERAPEUTICS INC | Healthcare | 1,478,329.0 | $28.9M | 0.93% | -1.3M | -45.9% | $19.56 | -6.5% |
| 22 | LEGN | LEGEND BIOTECH CORP | Healthcare | 1,298,142.0 | $28.2M | 0.90% | -528K | -28.9% | $21.74 | +31.6% |
| 23 | DHR | DANAHER CORPORATION | Healthcare | 118,227.0 | $27.1M | 0.87% | -191K | -61.8% | $228.92 | -28.1% |
| 24 | ARGX | ARGENX SE | Healthcare | 31,007.0 | $26.1M | 0.83% | -45K | -59.2% | $840.95 | -5.0% |
| 25 | KIDS | ORTHOPEDIATRICS CORP | Healthcare | 1,100,370.0 | $19.5M | 0.62% | -7K | -0.7% | $17.76 | +0.8% |
| 26 | HROW | HARROW INC | Healthcare | 295,291.0 | $14.5M | 0.46% | -47K | -13.8% | $49.00 | -37.0% |
| 27 | RGEN | REPLIGEN CORP | Healthcare | 81,790.0 | $13.4M | 0.43% | -114K | -58.2% | $163.86 | -36.9% |
| 28 | — | KINIKSA PHARMACEUTICALS INTL | — | 313,823.0 | $12.9M | 0.41% | -329K | -51.2% | $41.25 | — |
| 29 | XNCR | XENCOR INC | Healthcare | 459,166.0 | $7.0M | 0.23% | -787K | -63.2% | $15.31 | -22.4% |
| 30 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 177,183.0 | $6.9M | 0.22% | -646K | -78.5% | $38.90 | -51.5% |
| 31 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 311,991.0 | $5.1M | 0.16% | -424K | -57.6% | $16.24 | -21.0% |
| 32 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 84,795.0 | $2.6M | 0.08% | -1.3M | -93.9% | $30.31 | +110.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%